Outcomes Following Flow-Cytometry Crossmatch-Positive Lung Transplants Managed With Peri-Operative Desensitization.

[1]  J. Christie,et al.  Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression , 2021, Clinical transplantation.

[2]  S. Keshavjee,et al.  Long‐term outcomes of sensitized lung transplant recipients after peri‐operative desensitization , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  M. Neuville,et al.  A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome , 2021, European Respiratory Journal.

[4]  M. Ospina,et al.  Clinical judgment versus lung allocation score in predicting lung transplant waitlist mortality , 2020, Clinical transplantation.

[5]  R. Hachem,et al.  Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  H. Mallidi,et al.  Clinical Outcomes of Lung Transplantation in the Presence of Donor-specific Antibodies. , 2019, Annals of the American Thoracic Society.

[7]  F. D'Ovidio,et al.  Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates , 2019, Annals of transplantation.

[8]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  K. Tinckam,et al.  Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff. , 2019, Hepatobiliary surgery and nutrition.

[10]  J. Crapo,et al.  Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals , 2019, Annals of the American Thoracic Society.

[11]  J. Friedewald,et al.  Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  S. Keshavjee,et al.  Identification of risk epitope mismatches associated with de novo donor‐specific HLA antibody development in cardiothoracic transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Jaakko Reinikainen,et al.  Time-varying covariates and coefficients in Cox regression models. , 2018, Annals of translational medicine.

[14]  Maciej Liskiewicz,et al.  Robust causal inference using Directed Acyclic Graphs: the R package , 2018 .

[15]  S. Keshavjee,et al.  Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  P. Camp,et al.  Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates. , 2014, American journal of respiratory and critical care medicine.

[17]  T. D’amico,et al.  Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. , 2000, The Annals of thoracic surgery.

[18]  D. Zander,et al.  Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. , 1999, Transplantation.

[19]  David M. Conrad,et al.  Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols. , 2018, Human immunology.

[20]  J. Rosenberg,et al.  A critical analysis of quantitating flow cytometry: the role of the crossmatch in 2014. , 2013, Clinical transplants.